Frankel AE - Search Results

1

Peptide toxins directed at the matrix dissolution systems of cancer cells.

Frankel AE, Bugge TH, Liu S, Vallera DA, Leppla SH. Frankel AE, et al. Protein Pept Lett. 2002 Feb;9(1):1-14. doi: 10.2174/0929866023409048. Protein Pept Lett. 2002. PMID: 12141918 Review.

2

Anthrax fusion protein therapy of cancer.

Frankel AE, Powell BL, Duesbery NS, Vande Woude GF, Leppla SH. Frankel AE, et al. Curr Protein Pept Sci. 2002 Aug;3(4):399-407. doi: 10.2174/1389203023380567. Curr Protein Pept Sci. 2002. PMID: 12370003 Review.

3

A urokinase-activated recombinant diphtheria toxin targeting the granulocyte-macrophage colony-stimulating factor receptor is selectively cytotoxic to human acute myeloid leukemia blasts.

Abi-Habib RJ, Liu S, Bugge TH, Leppla SH, Frankel AE. Abi-Habib RJ, et al. Among authors: frankel ae. Blood. 2004 Oct 1;104(7):2143-8. doi: 10.1182/blood-2004-01-0339. Epub 2004 May 25. Blood. 2004. PMID: 15161668 Free article.

4

Diphtheria toxin-murine granulocyte-macrophage colony-stimulating factor-induced hepatotoxicity is mediated by Kupffer cells.

Westcott MM, Abi-Habib RJ, Cohen KA, Willingham MC, Liu S, Bugge TH, Leppla SH, Frankel AE. Westcott MM, et al. Among authors: frankel ae. Mol Cancer Ther. 2004 Dec;3(12):1681-9. Mol Cancer Ther. 2004. PMID: 15634662

5

BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.

Abi-Habib RJ, Urieto JO, Liu S, Leppla SH, Duesbery NS, Frankel AE. Abi-Habib RJ, et al. Among authors: frankel ae. Mol Cancer Ther. 2005 Sep;4(9):1303-10. doi: 10.1158/1535-7163.MCT-05-0145. Mol Cancer Ther. 2005. PMID: 16170021

6

Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.

Frankel AE, Beran M, Hogge DE, Powell BL, Thorburn A, Chen YQ, Vallera DA. Frankel AE, et al. Exp Hematol. 2002 Nov;30(11):1316-23. doi: 10.1016/s0301-472x(02)00925-6. Exp Hematol. 2002. PMID: 12423685 Free article.

7

The diphtheria toxin/urokinase fusion protein (DTAT) is selectively toxic to CD87 expressing leukemic cells.

Ramage JG, Vallera DA, Black JH, Aplan PD, Kees UR, Frankel AE. Ramage JG, et al. Among authors: frankel ae. Leuk Res. 2003 Jan;27(1):79-84. doi: 10.1016/s0145-2126(02)00077-2. Leuk Res. 2003. PMID: 12479856

8

Immunotoxin therapy of hematologic malignancies.

Frankel AE, Neville DM, Bugge TA, Kreitman RJ, Leppla SH. Frankel AE, et al. Semin Oncol. 2003 Aug;30(4):545-57. doi: 10.1016/s0093-7754(03)00241-0. Semin Oncol. 2003. PMID: 12939723 Review.

9

Novel protein targeted therapy of metastatic melanoma.

Frankel AE, Koo HM, Leppla SH, Duesbery NS, Vande Woude GF. Frankel AE, et al. Curr Pharm Des. 2003;9(25):2060-6. doi: 10.2174/1381612033454162. Curr Pharm Des. 2003. PMID: 14552326 Review.

10

Chimeric fusion proteins--diphtheria toxin-based.

Frankel AE, Powell BL, Vallera DA, Neville DM Jr. Frankel AE, et al. Curr Opin Investig Drugs. 2001 Sep;2(9):1294-301. Curr Opin Investig Drugs. 2001. PMID: 11717818 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

248 results

Search Page